Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease
Yijie Song, Yuge Zhao, Yueming Ma, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 60, pp. 61-75
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3
Xin Liu, Yi Fang, Xinting Lv, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 6, pp. 1457-1471
Open Access | Times Cited: 41
NLRP3 Inflammasome: A key contributor to the inflammation formation
Wen-Juan Zhang, Kejun Li, Lan Yi, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113683-113683
Closed Access | Times Cited: 37
Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
Yaxi Zhou, Diandian Wang, Wenjie Yan
Nutrients (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 36
Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cells
Jing Ma, Jiaqi Zhang, Yifan Wang, et al.
Phytomedicine (2023) Vol. 111, pp. 154660-154660
Open Access | Times Cited: 33
Pyroptosis: a new insight into intestinal inflammation and cancer
Limin Chao, Wenjing Zhang, Yuchao Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Pulchinenoside B4 alleviates DSS-induced colitis by inhibiting CD1d-dependent NLRP3 inflammasome activation in macrophages
Jiao Li, Li Pan, Shuo Yuan, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114118-114118
Closed Access | Times Cited: 1
Linarin ameliorates dextran sulfate sodium-induced colitis in C57BL/6J mice via the improvement of intestinal barrier, suppression of inflammatory responses and modulation of gut microbiota
Chengni Jin, Jiayu Liu, Ruyi Jin, et al.
Food & Function (2022) Vol. 13, Iss. 20, pp. 10574-10586
Closed Access | Times Cited: 30
Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis
Yang Ding, Zixu Wang, Yaoxing Chen, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2215-2227
Open Access | Times Cited: 19
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 17
Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
Annalisa Marcuzzi, E. Melloni, Giorgio Zauli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11241-11241
Open Access | Times Cited: 33
The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease
Yaxin Wu, Xin Di, Min Zhao, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 12
Open Access | Times Cited: 23
Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review
Rosa Direito, Sandra Maria Barbalho, Maria Eduardo Figueira, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 728-728
Open Access | Times Cited: 16
Association of serum lipids with inflammatory bowel disease: a systematic review and meta-analysis
Hongxin Chen, Weiyang Li, Jingyi Hu, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 15
Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors
Shengying Lou, Miaolian Wu, Sunliang Cui
Current Medicinal Chemistry (2024) Vol. 31, Iss. 15, pp. 2021-2051
Closed Access | Times Cited: 5
Huajuxiaoji Formula Alleviates Phenyl Sulfate‐Induced Diabetic Kidney Disease by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis
Zeng Zhang, Yueping Bi, Fengzhu Zhou, et al.
Journal of Diabetes Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5
Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
Harsh Vardhan Charan, Durgesh Kumar Dwivedi, Sabbir Khan, et al.
Genes & Diseases (2022) Vol. 10, Iss. 2, pp. 480-494
Open Access | Times Cited: 22
NLRP3 and Gut Microbiota Homeostasis: Progress in Research
Hongming Pan, Yuting Jian, Feijie Wang, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3758-3758
Open Access | Times Cited: 22
Tectoridin ameliorates proliferation and inflammation in TNF-α-induced HFLS-RA cells via suppressing the TLR4/NLRP3/NF-κB signaling pathway
Xiaofeng Niu, Huixin Song, Xin Xiao, et al.
Tissue and Cell (2022) Vol. 77, pp. 101826-101826
Closed Access | Times Cited: 20
Microbe-Derived Antioxidants Protect IPEC-1 Cells from H2O2-Induced Oxidative Stress, Inflammation and Tight Junction Protein Disruption via Activating the Nrf2 Pathway to Inhibit the ROS/NLRP3/IL-1β Signaling Pathway
Cheng Shen, Zhen Luo, Sheng Ma, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 533-533
Open Access | Times Cited: 4
Cinnamaldehyde, A Bioactive Compound from the Leaves of Cinnamomum osmophloeum Kaneh, Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Inhibiting the NLRP3 Inflammasome
May-Lan Liu, Wei-Ting Wong, Yih‐Ming Weng, et al.
Journal of physiological investigation. (2024) Vol. 67, Iss. 3, pp. 139-152
Open Access | Times Cited: 4
Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis
Yingnan Hu, Jingyi Tang, Dian Yu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3
Suqin Zhong, Suzhen Zhong, Yi Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 417-432
Closed Access
Nanocarriers in inflammatory bowel disease and colorectal cancer
Ankita Wal, Pranay Wal, Deependra Singh, et al.
Elsevier eBooks (2025), pp. 657-687
Closed Access
Baicalin n-butyl ester alleviates inflammatory bowel disease and inhibits pyroptosis through the ROS/ERK/P-ERK/NLRP3 pathway in vivo and in vitro
Mengru Guo, Huining Wu, Jilei Zhang, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118012-118012
Closed Access
Role of guanylate-binding protein 5 in inflammatory diseases, immune diseases, cancers, and its potential therapeutic implications
Xufan Sun, Guiyuan Jin, Huihui Zhou, et al.
Inflammopharmacology (2025)
Closed Access
Page 1 - Next Page

Scroll to top